Literature DB >> 8388839

Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats.

C C Sieber1, J C Lopez-Talavera, R J Groszmann.   

Abstract

BACKGROUND: The locally acting vasodilator nitric oxide has recently been implicated as a possible mediator in the vasodilatation observed in prehepatic portal hypertension. The aim of this study was to assess if nitric oxide could also be implicated in the vasodilation observed in experimental cirrhosis.
METHODS: In an in vitro preparation, the vascular responsiveness to potassium chloride of Krebs'-perfused superior mesenteric arterial vascular beds of control (n = 12) and cirrhotic (n = 10) rats with ascites, induced by CCl4, were tested.
RESULTS: Increases in perfusion pressures over baseline in response to potassium chloride (125 mmol/L) were significantly lower in vessel preparations of cirrhotic rats (84.7 +/- 12.3 and 134.2 +/- 16.3 mmHg for cirrhotic and control rats, respectively, P < 0.05). This hyporeactivity was overcome by incubating the same vessel preparations with the stereospecific nitric oxide biosynthesis antagonist N omega-nitro-L-arginine (10(-4) mol/L). The corresponding increases in perfusion pressures were 145.1 +/- 18.0 and 173.0 +/- 14.8 mm Hg for cirrhotic and control rats, respectively (P = NS). Nitric oxide formation blockade increased the vascular response to KCl in cirrhotic and control rats, the respective percentage changes being 84.6% +/- 14.8% and 38.5% +/- 12.1% (P < 0.05).
CONCLUSIONS: (1) Superior mesenteric arterial vascular beds of cirrhotic rats express a significant contracting hyporeactivity to KCl and (2) nitric oxide at least partly mediates the hyporesponsiveness in this in vitro preparation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388839     DOI: 10.1016/0016-5085(93)90655-v

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility.

Authors:  R Wiest; S Das; G Cadelina; G Garcia-Tsao; S Milstien; R J Groszmann
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

Review 3.  Pathophysiology of portal hypertension and its clinical links.

Authors:  Yeon Seok Seo; Vijay H Shah
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 4.  Animal models of portal hypertension.

Authors:  Juan-G Abraldes; Marcos Pasarín; Juan-Carlos García-Pagán
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

5.  Interaction of nitric oxide with calcium in the mesenteric bed of bile duct-ligated rats.

Authors:  F Javier A Nadal; Noemí M Atucha; David Iyu; Joaquín García-Estañ
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  A new rat model of portal hypertension induced by intraportal injection of microspheres.

Authors:  Xiang-Nong Li; IS Benjamin; B Alexander
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

Review 7.  Pathophysiology and Management of Variceal Bleeding.

Authors:  Saleh A Alqahtani; Sunguk Jang
Journal:  Drugs       Date:  2021-03-12       Impact factor: 9.546

8.  Hepatic and splanchnic nitric oxide activity in patients with cirrhosis.

Authors:  A I Sarela; F M Mihaimeed; J J Batten; B R Davidson; R T Mathie
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

9.  Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.

Authors:  J C López-Talavera; A Levitzki; M Martínez; A Gazit; R Esteban; J Guardia
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

10.  Therapeutic potential of targeting the renin angiotensin system in portal hypertension.

Authors:  Chandana B Herath; Josephine A Grace; Peter W Angus
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.